Sarah Nemec
About Sarah Nemec
Sarah Nemec Vice President of Finance at Bolt Biotherapeutics
Sarah Nemec serves as the Vice President of Finance at Bolt Biotherapeutics, a position she has held since joining the company in 2020. She has more than 20 years of experience as a senior finance leader in the life science industry. At Bolt, Sarah played a pivotal role in the company's initial public offering and was instrumental in establishing the company's financial management infrastructure, including key reporting systems and processes.
Sarah Nemec Career at BioElectron Technology Corp.
Before joining Bolt Biotherapeutics, Sarah Nemec held the position of Vice President and Principal Accounting Executive at BioElectron Technology Corp. In this role, she led the accounting and cash management functions through the sale and transition of the company's assets to PTC Therapeutics. Her leadership was critical in ensuring a smooth transition during this period.
Sarah Nemec Experience at JDA Software and Affymetrix
Sarah Nemec's career also includes serving as the Director of Financial Reporting for JDA Software, now known as Blue Yonder. Additionally, she was the Associate Director of SEC Reporting for Affymetrix, which has since been acquired by Thermo Fisher Scientific. These roles further solidified her expertise in financial reporting and compliance in the life sciences and software industries.
Sarah Nemec Early Career and Education
Sarah Nemec began her career as an auditor at Ernst & Young, LLP in their financial services and life science practice. She is a certified public accountant and earned both her bachelor's and master's degrees in accounting from Ohio University. Her early experience in auditing laid a strong foundation for her subsequent roles in financial leadership.